Skip to main content
. 2006 Apr 19;2006(2):CD005321. doi: 10.1002/14651858.CD005321.pub2

31.4. Analysis.

31.4

Comparison 31 NRD‐101 (Suvenyl) versus placebo (saline plus oral placebo), Outcome 4 Percentage of painful days (0‐100 mm VAS) change between baseline and 45 to 52 weeks post‐injection.